tiprankstipranks
Dimed S.A. Distribuidora de Medicamentos (BR:PNVL3)
:PNVL3
Brazil Market

Dimed S.A. Distribuidora de Medicamentos (PNVL3) Stock Statistics & Valuation Metrics

Followers

Total Valuation

Dimed S.A. Distribuidora de Medicamentos has a market cap or net worth of R$1.76B. The enterprise value is $3.24K.
Market CapR$1.76B
Enterprise Value$3.24K

Share Statistics

Dimed S.A. Distribuidora de Medicamentos has 150,377,490 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding150,377,490
Owned by Insiders
Owned by Institutions

Financial Efficiency

Dimed S.A. Distribuidora de Medicamentos’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 7.19%.
Return on Equity (ROE)0.10
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)7.19%
Return on Capital Employed (ROCE)0.09
Revenue Per Employee496.23K
Profits Per Employee11.22K
Employee Count11,108
Asset Turnover1.44
Inventory Turnover3.39

Valuation Ratios

The current PE Ratio of Dimed S.A. Distribuidora de Medicamentos is 13.3. Dimed S.A. Distribuidora de Medicamentos’s PEG ratio is 0.78.
PE Ratio13.3
PS Ratio0.32
PB Ratio1.39
Price to Fair Value1.39
Price to FCF5.97
Price to Operating Cash Flow4.51
PEG Ratio0.78

Income Statement

In the last 12 months, Dimed S.A. Distribuidora de Medicamentos had revenue of 5.51B and earned 124.61M in profits. Earnings per share was 0.84.
Revenue5.51B
Gross Profit1.55B
Operating Income238.29M
Pretax Income145.54M
Net Income124.61M
EBITDA470.83M
Earnings Per Share (EPS)0.84

Cash Flow

In the last 12 months, operating cash flow was 394.01M and capital expenditures -128.21M, giving a free cash flow of 265.81M billion.
Operating Cash Flow394.01M
Free Cash Flow265.81M
Free Cash Flow per Share1.77

Dividends & Yields

Dimed S.A. Distribuidora de Medicamentos pays an annual dividend of $0.121, resulting in a dividend yield of ―
Dividend Per Share$0.121
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.94
52-Week Price Change32.13%
50-Day Moving Average
200-Day Moving Average
Relative Strength Index (RSI)
Average Volume (3m)

Important Dates

Dimed S.A. Distribuidora de Medicamentos upcoming earnings date is Aug 6, 2026, TBA (Confirmed).
Last Earnings DateMay 6, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date

Financial Position

Dimed S.A. Distribuidora de Medicamentos as a current ratio of 1.74, with Debt / Equity ratio of 106.57%
Current Ratio1.74
Quick Ratio0.86
Debt to Market Cap0.40
Net Debt to EBITDA3.11
Interest Coverage Ratio1.72

Taxes

In the past 12 months, Dimed S.A. Distribuidora de Medicamentos has paid 20.93M in taxes.
Income Tax20.93M
Effective Tax Rate0.14

Enterprise Valuation

Dimed S.A. Distribuidora de Medicamentos EV to EBITDA ratio is 6.90, with an EV/FCF ratio of 10.86.
EV to Sales0.59
EV to EBITDA6.90
EV to Free Cash Flow10.86
EV to Operating Cash Flow7.71

Balance Sheet

Dimed S.A. Distribuidora de Medicamentos has R$304.00M in cash and marketable securities with R$1.39B in debt, giving a net cash position of -R$1.08B billion.
Cash & Marketable SecuritiesR$304.00M
Total DebtR$1.39B
Net Cash-R$1.08B
Net Cash Per Share-R$7.19
Tangible Book Value Per ShareR$7.87

Margins

Gross margin is 29.23%, with operating margin of 4.32%, and net profit margin of 2.26%.
Gross Margin29.23%
Operating Margin4.32%
Pretax Margin2.64%
Net Profit Margin2.26%
EBITDA Margin8.54%
EBIT Margin4.32%

Analyst Forecast

The average price target for Dimed S.A. Distribuidora de Medicamentos is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast14.63%
EPS Growth Forecast35.91%

Scores

Smart ScoreN/A
AI Score